From the 40 business journals of American City Business Journals …
Genzyme ordered to pay $50M to settle patent dispute (Boston Business Journal)
The path Anido will take as NuPathe CEO (Philadelphia Business Journal)
Armando Anido said his first order of business as the new CEO of NuPathe Inc.will be to go out and raise money for the Conshohocken, Pa., biopharmaceutical company.
Related story: Area drug firm's founder/CEO resigns (Philadelphia Business Journal)
Chimerix strikes drug licensing deal with Merck (Triangle Business Journal)
NantPharma gets $125M investment from Blackstone (Los Angeles Business)
QR Pharma begins human testing of Alzheimer's treatment (Philadelphia Business Journal)
State awards U of M Medical Devices Center $1 million (Minneapolis/St. Paul Business Journal)
The University of Minnesota Medical Devices Center will build a new facility on the school's West Bank campus, thanks to a $1.08 million grant from the Minnesota Department of Employment of Economic Development (DEED).
Corindus wins FDA nod for robotic heart procedure (Boston Business Journal)
Greatbatch Q2 net income takes fall as sales climb (Buffalo Business First)
Greatbatch Inc. reported second-quarter profit dropped to $3.85 million from $8.55 million a year ago at despite record sales. The implantable medical device manufacturer (NYSE: GB) said sales increased 14 percent to $166.5 million, from $146.5 million in the 2010 second quarter.